Consumer Food · Founded 1993 · www.ovobelfoods.com · BSE 530741 · · ISIN INE812S01012
No Notes Added Yet
Business
Ovobel Foods Ltd. is an Indian company primarily engaged in the manufacturing and processing of value-added egg products. The company sources raw eggs and processes them into various forms such as whole egg powder, egg yolk powder, egg albumen powder, liquid egg products, and frozen egg products. Its core business model is B2B, supplying these processed egg ingredients to various industries including food processing, bakeries, confectionery, noodles, pasta, ice creams, mayonnaise, cosmetics, and pharmaceuticals. The company makes money by adding value to raw eggs through advanced processing, ensuring longer shelf life, ease of use, and specific functional properties for industrial applications, and then selling these finished products to domestic and international clients.
Revenue Mix
The company's primary business revolves entirely around processed egg products. While specific revenue contributions by product type (powder, liquid, frozen) are typically not separately reported in general public domain overviews, the core focus is on these value-added egg ingredients. The company serves both the domestic Indian market and has a significant export presence, indicating a geographical revenue mix between India and international markets. Exports often form a substantial portion of its revenue, driven by global demand for specialized egg ingredients.
Industry
Ovobel Foods operates within the consumer food industry, specifically in the niche but growing segment of egg processing and ingredient supply. The Indian egg processing industry is relatively organized, driven by increasing demand for convenience foods, bakery products, confectionery, and other processed items that require egg-based ingredients. The shift from shell eggs to processed egg products by industrial users due to benefits like convenience, safety, and extended shelf-life is a key trend. Ovobel is an established player in this segment, competing with other domestic egg processors and specialized ingredient suppliers. Its positioning is as a reliable supplier of quality egg ingredients to industrial customers.
MOAT
Specialized Processing Capabilities & Certifications: Ovobel possesses specialized manufacturing facilities and technical expertise in egg processing. Its ability to produce various forms of egg products (powder, liquid, frozen) with specific functional properties is a differentiation. Holding international food safety and quality certifications (e.g., FSSAI, ISO, HACCP, often EU approval for exports) is crucial for B2B customers and provides a barrier to entry for new players, especially for export markets.
Customer Relationships: Over time, the company likely builds long-standing relationships and trust with industrial customers, which can lead to repeat business and preferred supplier status due to consistent quality and supply.
Scale of Operations: As an established player, it likely benefits from economies of scale in raw material sourcing and processing efficiencies compared to smaller or newer entrants.
Growth Drivers
Rising Demand for Processed Foods: Increasing urbanization, disposable incomes, and changing lifestyles in India are driving the consumption of processed foods, bakery, and confectionery items, which are major users of egg ingredients.
Global Protein Demand: Growing global awareness and demand for protein-rich diets can fuel demand for egg-based products.
Export Opportunities: Expansion into new international markets and deeper penetration in existing ones, leveraging quality certifications and competitive pricing.
Shift to Value-Added Ingredients: Industrial consumers increasingly prefer processed egg products over shell eggs due to benefits in terms of hygiene, consistency, ease of storage, and longer shelf life.
Product Innovation: Development of new egg-based ingredients with enhanced functionalities to cater to evolving customer needs in food and non-food industries.
Risks
Raw Material Price Volatility: The price of raw eggs, the primary input, is subject to significant volatility due to seasonal factors, feed costs, and supply-demand imbalances, impacting profit margins.
Disease Outbreaks: Outbreaks of avian diseases (e.g., avian flu) can severely disrupt egg supply, lead to culling, impact consumer confidence, and result in trade restrictions, affecting both sourcing and sales.
Regulatory Changes: Changes in food safety regulations, import/export policies, and environmental norms can impact operations and costs.
Competition: Intense competition from domestic and international egg processors can put pressure on pricing and market share.
Currency Fluctuations: For a company with significant exports, adverse currency movements can impact revenue realizations and profitability.
Energy Costs: Egg processing is energy-intensive, making the company susceptible to fluctuations in energy prices.
Management & Ownership
Ovobel Foods Ltd. is typically driven by its promoter group, who often hold a significant majority stake in the company. The promoters are actively involved in the management and strategic direction of the business. Such a high promoter holding often indicates strong alignment between ownership and management interests. Specific details about individual management quality would require a deeper dive into their public disclosures and track record, but the operational existence and growth suggest a competent management team focused on the specialized egg processing sector.
Outlook
Ovobel Foods is positioned in a growing segment driven by increasing demand for processed foods and protein globally. Its focus on value-added B2B egg ingredients, coupled with a strong emphasis on quality and certifications, provides a solid foundation for growth, especially in export markets. However, the business faces inherent challenges such as the high volatility of raw egg prices and the recurring threat of avian diseases, which can significantly impact operations and profitability. The company's ability to effectively manage input costs, diversify customer base, and maintain stringent quality standards will be crucial for sustained performance amidst industry-specific risks and competition.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 29 | 48 | 42 | 51 | 48 | 61 | 57 | 74 | 65 | 80 |
| Other Income | 1 | 2 | 2 | 3 | 2 | 1 | 3 | 4 | 7 | 4 |
| Total Income | 30 | 49 | 44 | 54 | 50 | 62 | 60 | 78 | 73 | 84 |
| Total Expenditure | 32 | 45 | 40 | 54 | 41 | 56 | 50 | 72 | 52 | 62 |
| Operating Profit | -2 | 4 | 3 | -1 | 9 | 5 | 10 | 5 | 21 | 22 |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -2 | 4 | 2 | -2 | 8 | 4 | 9 | 4 | 19 | 21 |
| Provision for Tax | -1 | 1 | 1 | -0 | 2 | 1 | 2 | 1 | 5 | 5 |
| Profit After Tax | -2 | 3 | 2 | -1 | 6 | 3 | 6 | 3 | 14 | 15 |
| Adjustments | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | -2 | 3 | 2 | -1 | 6 | 3 | 6 | 3 | 14 | 15 |
| Adjusted Earnings Per Share | -1.9 | 2.9 | 1.7 | -1.2 | 6.2 | 2.9 | 6.7 | 2.9 | 14.9 | 16.2 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 98 | 106 | 75 | 83 | 97 | 109 | 111 | 125 | 221 | 175 | 189 | 276 |
| Other Income | 8 | 10 | 5 | 16 | 15 | 8 | 6 | 2 | 3 | 5 | 7 | 18 |
| Total Income | 107 | 115 | 81 | 100 | 112 | 117 | 117 | 127 | 225 | 180 | 196 | 295 |
| Total Expenditure | 92 | 107 | 81 | 92 | 102 | 111 | 117 | 125 | 170 | 153 | 180 | 236 |
| Operating Profit | 15 | 8 | -1 | 7 | 10 | 6 | -1 | 2 | 55 | 26 | 16 | 58 |
| Interest | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 0 |
| Depreciation | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 4 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 13 | 6 | -3 | 5 | 8 | 4 | -3 | 0 | 53 | 24 | 12 | 53 |
| Provision for Tax | 4 | 2 | 1 | 1 | 3 | 1 | -1 | 0 | 14 | 6 | 3 | 13 |
| Profit After Tax | 9 | 4 | -4 | 5 | 6 | 3 | -2 | 0 | 39 | 18 | 9 | 38 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 9 | 4 | -4 | 5 | 6 | 3 | -2 | 0 | 39 | 18 | 9 | 38 |
| Adjusted Earnings Per Share | 8.8 | 4 | -3.3 | 4.3 | 5.4 | 2.6 | -1.7 | 0 | 40.9 | 18.8 | 9.5 | 40.7 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 8% | 15% | 12% | 7% |
| Operating Profit CAGR | -38% | 100% | 22% | 1% |
| PAT CAGR | -50% | 0% | 25% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 137% | 4% | 56% | 30% |
| ROE Average | 11% | 45% | 26% | 51% |
| ROCE Average | 14% | 41% | 24% | 27% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 10 | 14 | 10 | 15 | 20 | 23 | 21 | 20 | 59 | 77 | 86 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 3 | 2 | 1 | 2 |
| Other Non-Current Liabilities | -0 | 0 | -1 | -1 | -0 | 0 | -1 | -1 | -0 | -0 | 1 |
| Total Current Liabilities | 44 | 44 | 39 | 27 | 16 | 18 | 21 | 32 | 39 | 24 | 38 |
| Total Liabilities | 55 | 60 | 50 | 41 | 36 | 41 | 42 | 55 | 100 | 102 | 127 |
| Fixed Assets | 2 | 3 | 5 | 4 | 4 | 3 | 4 | 3 | 3 | 13 | 28 |
| Other Non-Current Assets | 1 | 0 | 3 | 2 | 1 | 2 | 1 | 1 | 10 | 17 | 35 |
| Total Current Assets | 52 | 57 | 42 | 35 | 32 | 36 | 38 | 51 | 87 | 72 | 64 |
| Total Assets | 55 | 60 | 50 | 41 | 36 | 41 | 42 | 55 | 100 | 102 | 127 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 5 | 3 | 6 | 6 | 6 | 8 | 1 | 0 | 6 | 6 | 1 |
| Cash Flow from Operating Activities | 8 | -2 | -3 | 1 | 3 | 1 | -1 | -5 | 41 | 7 | 4 |
| Cash Flow from Investing Activities | -7 | 1 | 4 | 0 | -0 | -0 | -2 | -0 | -41 | -1 | -9 |
| Cash Flow from Financing Activities | -2 | -1 | -1 | -1 | -1 | -0 | 3 | 11 | 0 | -11 | 6 |
| Net Cash Inflow / Outflow | -1 | -3 | -0 | 0 | 1 | 0 | -0 | 6 | 0 | -5 | 1 |
| Closing Cash & Cash Equivalent | 3 | 0 | 6 | 6 | 8 | 8 | 0 | 6 | 6 | 1 | 2 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 8.78 | 3.98 | -3.34 | 4.31 | 5.38 | 2.59 | -1.72 | 0.02 | 40.86 | 18.83 | 9.53 |
| CEPS(Rs) | 9.03 | 4.51 | -2.35 | 5.52 | 6.32 | 3.58 | -0.89 | 0.97 | 41.67 | 19.86 | 11.64 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 9.25 | 13.23 | 9.67 | 13.92 | 19.32 | 21.59 | 19.86 | 21.05 | 62.01 | 80.66 | 90.07 |
| Core EBITDA Margin(%) | 6.54 | -1.14 | -7.98 | -10.65 | -4.68 | -2.04 | -5.72 | -0.06 | 23.21 | 12 | 4.62 |
| EBIT Margin(%) | 14.82 | 7.31 | -2.48 | 7.42 | 9.54 | 4.38 | -1.29 | 0.77 | 24.41 | 14.38 | 7.48 |
| Pre Tax Margin(%) | 13.58 | 5.8 | -3.82 | 6.3 | 8.64 | 3.54 | -2.33 | 0.1 | 23.76 | 13.48 | 6.57 |
| PAT Margin (%) | 9.32 | 3.93 | -4.61 | 5.42 | 5.81 | 2.5 | -1.63 | 0.01 | 17.54 | 10.1 | 4.8 |
| Cash Profit Margin (%) | 9.59 | 4.45 | -3.25 | 6.93 | 6.82 | 3.46 | -0.84 | 0.74 | 17.89 | 10.65 | 5.87 |
| ROA(%) | 20.05 | 7.32 | -6.4 | 9.95 | 14.6 | 7.06 | -4.39 | 0.04 | 50.31 | 17.77 | 7.93 |
| ROE(%) | 350.02 | 35.42 | -29.2 | 36.58 | 32.39 | 12.66 | -8.32 | 0.08 | 98.39 | 26.4 | 11.17 |
| ROCE(%) | 89.75 | 28.61 | -7.4 | 25.08 | 31.74 | 14.29 | -4.02 | 2.32 | 80.29 | 27.74 | 13.53 |
| Receivable days | 44.06 | 51.72 | 67.98 | 50.03 | 35.55 | 24.38 | 27.96 | 30.62 | 24.27 | 26.64 | 18.25 |
| Inventory Days | 23.36 | 24.52 | 49.71 | 47.61 | 37.04 | 40.81 | 43.12 | 44.07 | 29.47 | 44.4 | 55.82 |
| Payable days | 21.27 | 15.05 | 13.5 | 10.38 | 13.76 | 10.72 | 9.71 | 11 | 7.41 | 6.64 | 6.82 |
| PER(x) | 0 | 0 | 0 | 5.03 | 2.52 | 6.6 | 0 | 1293.3 | 3.2 | 10.45 | 6.22 |
| Price/Book(x) | 0 | 0 | 2.84 | 1.56 | 0.7 | 0.79 | 1.64 | 1.1 | 2.11 | 2.44 | 0.66 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.05 | 0.11 | 0.47 | 0.34 | 0.18 | 0.2 | 0.37 | 0.27 | 0.47 | 1.03 | 0.38 |
| EV/Core EBITDA(x) | 0.35 | 1.43 | -41.82 | 3.78 | 1.75 | 3.77 | -73.8 | 18.17 | 1.92 | 6.78 | 4.48 |
| Net Sales Growth(%) | -6.75 | 7.4 | -28.63 | 10.71 | 16.64 | 11.72 | 1.86 | 12.97 | 76.95 | -21.11 | 8 |
| EBIT Growth(%) | -24.21 | -46.89 | -124.29 | 428.05 | 49.67 | -48.66 | -130.05 | 167.63 | 5479.95 | -52.86 | -44.6 |
| PAT Growth(%) | 336.69 | -54.66 | -183.97 | 229.03 | 24.81 | -51.9 | -166.56 | 100.94 | 0 | -53.92 | -49.37 |
| EPS Growth(%) | 336.71 | -54.66 | -183.97 | 229.02 | 24.81 | -51.9 | -166.56 | 101.04 | 0 | -53.92 | -49.37 |
| Debt/Equity(x) | 1.69 | 1.03 | 1.25 | 0.82 | 0.57 | 0.53 | 0.75 | 1.35 | 0.49 | 0.25 | 0.31 |
| Current Ratio(x) | 1.18 | 1.29 | 1.08 | 1.33 | 1.97 | 2 | 1.75 | 1.6 | 2.24 | 3.01 | 1.66 |
| Quick Ratio(x) | 1.04 | 1.1 | 0.76 | 0.99 | 1.32 | 1.24 | 1.17 | 1.05 | 1.78 | 1.96 | 0.81 |
| Interest Cover(x) | 12.01 | 4.83 | -1.85 | 6.67 | 10.62 | 5.2 | -1.25 | 1.15 | 37.65 | 15.98 | 8.18 |
| Total Debt/Mcap(x) | 0 | 0 | 0.44 | 0.52 | 0.82 | 0.68 | 0.46 | 1.11 | 0.23 | 0.1 | 0.48 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 68.71 | 68.42 | 68.42 | 68.42 | 68.95 | 69.24 | 69.24 | 69.65 | 69.65 | 69.65 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Public | 31.29 | 31.57 | 31.57 | 31.57 | 31.05 | 30.75 | 30.75 | 30.34 | 30.34 | 30.34 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.65 | 0.65 | 0.65 | 0.65 | 0.66 | 0.66 | 0.66 | 0.66 | 0.66 | 0.66 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.3 | 0.3 | 0.3 | 0.3 | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +8% | +15% | +12% | +7% |
| Operating Profit CAGR | -38% | +100% | +22% | +1% |
| PAT CAGR | -50% | — | +25% | 0% |
| Share Price CAGR | +137% | +4% | +56% | +30% |
| ROE Average | +11% | +45% | +26% | +51% |
| ROCE Average | +14% | +41% | +24% | +27% |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 68.71 | 68.42 | 68.42 | 68.42 | 68.95 | 69.24 | 69.24 | 69.65 | 69.65 | 69.65 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Public | 31.29 | 31.57 | 31.57 | 31.57 | 31.05 | 30.75 | 30.75 | 30.34 | 30.34 | 30.34 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.65 | 0.65 | 0.65 | 0.65 | 0.66 | 0.66 | 0.66 | 0.66 | 0.66 | 0.66 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.3 | 0.3 | 0.3 | 0.3 | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.